Press-release for stocks publishing date 2022 - 01

Prices are updated after-hours

publishing date : 2022 - 01 - 06 source : Www.biospace.com

save search

Glaukos Announces FDA 510(k) Clearance of iPRIME™
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
GKOS | $100.93 -0.17% 0.0% 520K

Health Technology

| 127.68% | O: 1.53% H: 0.0% C: 0.0%
fda clearance

Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Model And Will Host Key External Expert Investor Event
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
IMRX | $1.5 -7.98% -8.67% 450K

| -90.31% | O: -0.78% H: 0.0% C: 0.0%
preclinical pre-clinical

Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -13.83% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M

Health Technology

| -21.16% | O: -0.46% H: 0.0% C: 0.0%
ADVM | News | $10.19 -7.36% -7.95% 400K

Health Technology

| 489.02% | O: 0.58% H: 0.0% C: 0.0%
eye star biotech iot

Singular Genomics Appoints Genomics Research Pioneer Elaine R. Mardis, Ph.D., to Board of Directors
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
OMIC | $0.4074 -1.69% 3.38% 34K

Professional, Scientific, and T...

| -95.48% | O: 4.85% H: 0.0% C: 0.0%
genomics genomic research

Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
OCDX | News | $17.63 0.45%

| -12.29% | O: 0.0% H: 0.0% C: 0.0%
QDEL | News 4 | $40.82 1.04% 1.0% 950K

Health Technology

| -67.2% | O: 0.6% H: 0.0% C: 0.0%
diagnostic financial results diagnostics

Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
BAX | $40.93 -0.22% 0.0% 2.2M

Health Technology

| -53.51% | O: -0.35% H: 0.0% C: 0.0%
financial results conference results

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021 Net Product Sales Results and Future Program Milestones
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
PPRUF | News | $345.01 1.47% 37.56% 1.6K

Consumer Non-Durables

| -57.73% | O: 2.64% H: 0.0% C: -0.39%
PPRUY | News | $34.9595 3.46% -0.11% 390K

Manufacturing

| -57.66% | O: -0.99% H: 0.0% C: -1.16%
TAK | News | $13.23 -1.12% 0.0% 920K

Health Technology

| -2.29% | O: 1.0% H: 0.0% C: 0.0%
NBIX | News 4 | $138.97 -0.8% -0.85% 930K

Health Technology

| 66.93% | O: 0.24% H: 0.0% C: 0.0%
sales bioscience milestone

4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-150, a Dual-Transgene Intravitreal Gene Therapy for Patients with wet AMD
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
FDMT M | $24.25 -2.26% -2.29% 290K

Health Technology

| 22.41% | O: 0.0% H: 0.0% C: 0.0%
gene therapy trial therapeutics phase 1 therapy molecular

Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxicity (DLT) in First Cohort of APOLLO 613 Phase
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
RFL 4 | $1.71 -4.09% 4.2K

Finance

| -63.46% | O: 5.98% H: 0.4% C: -2.62%
als ces 613

Cyclacel Pharmaceuticals Reviews 2021 Achievements And Announces Key Business Objectives for 2022
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
CYCC | $2.2999 28.49% 22.17% 490K

Health Technology

| -44.31% | O: -1.33% H: 1.84% C: -2.33%
als ces cel

Conformis, Inc. Provides Business Update and Initial Expectations for 2022
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
CFMS | $2.26 0.44% 0

Health Technology

| 209.77% | O: 5.08% H: 1.3% C: -7.48%

Lilly to Participate in the J.P. Morgan Healthcare Conference
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.84% 1.7M

Health Technology

| 179.8% | O: -2.81% H: 0.0% C: 0.0%
health thc conference j.p. morgan healthcare conference

Pamela Shipley to lead Kaiser Permanente Georgia
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
CNC | $76.19 0.46% 0.85% 1.6M

Health Services

| -6.14% | O: -3.91% H: 2.27% C: -2.13%

CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: 2022-01-06 (Crawled : 21:00) - biospace.com/
CNSP | News | $0.214 1.91% -4.9% 75K

Health Technology

| -80.0% | O: -24.76% H: 1.27% C: -3.8%
als nasdaq

Freeline Announces FDA Clearance of Investigational New Drug Application for FLT201 for Gaucher Disease Type 1
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
FRLN | $6.48 0.0% 0

Health Technology

| 230.61% | O: 32.65% H: 1.15% C: -23.85%
flt201 new drug fda clearance application drug disease fda clearance

Finch Therapeutics Further Strengthens Patent Portfolio with Two New U.S. Patents Granted for FIN-211, an Investigational Microbiome Therapeutic in Development for Autism Spectrum Disorder
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
FNCH | $2.3 -17.53% -20.99% 120K

Professional, Scientific, and T...

| -75.58% | O: 0.64% H: 3.48% C: -2.53%
fin-211 order patent granted therapeutics ism

Humacyte Announces Presentation of First Eight Expanded Access Cases Using Human Acellular Vessel™ (HAV) for Treatment of Critical Limb Ischemia at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
HUMA | $3.82 -2.8% -2.88% 1.5M

Manufacturing

| -43.32% | O: -1.78% H: 0.45% C: -6.95%
treatment ces presentation cel

ObsEva Announces Positive Topline Results for Linzagolix 200 mg with Add-Back Therapy in the Phase 3 EDELWEISS 3 Trial in Patients with Moderate-to-Severe Endometriosis-Associated Pain
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
OBSV | $0.1018 -15.52% -18.95% 8.2M

Health Technology

| -95.06% | O: 1.94% H: 0.48% C: -4.76%
trial topline results positive therapy linzagolix topline phase 3

First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
FWBI | $3.02 -3.21% -2.63% 36K

Manufacturing

| 97.39% | O: 0.0% H: 2.61% C: -3.92%
covid-19 phase 2 biopharma trial covid infection enroll infections

SomaLogic and Illumina Combine Strengths to Propel Innovation in Proteomics
Published: 2022-01-06 (Crawled : 20:00) - biospace.com/
ILMN | $122.87 -1.28% -1.4% 720K

Health Technology

| -66.6% | O: -0.14% H: 4.37% C: 3.15%